Exchange: NASDAQ·Updated 07:53 PM EDT

OCUP Ocuphire Pharma Inc

$5.18
$0.10
(1.89%)
Today
Closed $5.18
$0.1045
(2.02%)
After Hours
EarningsNov 11
Mkt Cap$439.27M
Vol5.54M

About OCUP

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
48

Neutral Sentiment

How do you feel about OCUP?

Advertisement|Remove ads.